Multimodal Investigation of Neural Plasticity (miniSTIM)
Multimodal Investigation of Neural Plasticity Induced by Non-invasive Brain Stimulation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Harini Babu, MSc
- Phone Number: 734-647-3704
- Email: hariniba@umich.edu
Study Contact Backup
- Name: Eileen Robinson, RN-BC
- Phone Number: 734-763-1356
- Email: robinsoe@med.umich.edu
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Recruiting
- University of Michigan
-
Principal Investigator:
- Alexandru Iordan, Ph.D
-
Contact:
- Alexandru Iordan, Ph.D
- Phone Number: 734-764-2909
- Email: adiordan@med.umich.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Normal cognition for HC and diagnosis of Mild Cognitive Impairment (MCI) for MCI participants
- Right-handedness
- Magnetic resonance compatible, criteria that also apply for high definition transcranial direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants in the upper body or head)
Exclusion Criteria:
- History of other contributing neurological or medical conditions known to affect cognitive functioning
- Significant mental illness
- Sensory impairments that limit ability to participate
- History of alcohol or drug abuse/dependence
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sham Comparator: HC sham tDCS
Sham (placebo) dose of HD-tDCS treatment for 20 minutes, for 1 session.
|
Participants will receive sham (placebo) HD-tDCS for 20 minutes, for 1 session.
|
|
Experimental: HC active tDCS
3 milliAmp dose of HD-tDCS treatment for 20 minutes, for 1 session.
|
Participants will receive HD-tDCS at 3 milliAmp for 20 minutes, for 1 session.
|
|
Sham Comparator: MCI sham tDCS
Sham (placebo) dose of HD-tDCS treatment for 20 minutes, for 1 session.
|
Participants will receive sham (placebo) HD-tDCS for 20 minutes, for 1 session.
|
|
Experimental: MCI active tDCS
3 milliAmp dose of HD-tDCS treatment for 20 minutes, for 1 session.
|
Participants will receive HD-tDCS at 3 milliAmp for 20 minutes, for 1 session.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in glutamate concentration (fMRS)
Time Frame: average on 1 week
|
Analyses via fMRS using units of concentration
|
average on 1 week
|
|
Changes in brain activation (fMRI)
Time Frame: average of 1 week
|
Analyses via fMRI using units of brain activation
|
average of 1 week
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in memory performance
Time Frame: average of 1 week
|
Analyses of memory performance indexed as percent accuracy
|
average of 1 week
|
|
Changes in brain activation (fNIRS)
Time Frame: immediate, concurrent with tDCS
|
Analyses via fNIRS using units of brain activation
|
immediate, concurrent with tDCS
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Alexandru Iordan, PhD, University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HUM00201483
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.